Product Description
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Eptifibatide Acetate is a synthetic cyclic heptapeptide glycoprotein IIb/IIIa inhibitor used in cardiology. The core process involves solid-phase peptide synthesis followed by acetate salt formation. <strong>Molecular Formula</strong>: C<sub>41</sub>H<sub>62</sub>N<sub>10</sub>O<sub>11</sub>S·C<sub>2</sub>H<sub>4</sub>O<sub>2</sub>. <strong>CAS No.</strong>: 159749-89-0.</p>
<h3>Application</h3>
<ul>
<li><strong>Cardiovascular Surgery</strong>: Prevents thrombotic complications during percutaneous coronary interventions (PCI).</li>
<li><strong>Acute Coronary Syndromes</strong>: Manages unstable angina and non-ST-elevation myocardial infarction.</li>
<li><strong>Pharmaceutical Manufacturing</strong>: Serves as high-purity API for injectable antiplatelet formulations.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated in patients with active internal bleeding or history of stroke within two months. Requires storage at controlled room temperature (20°C to 25°C) in dry, light-resistant conditions to maintain stability.